Expression of HER4 isoforms and HER4 localisation in HER2 negative breast cancer cell lines
Breast cancer is the most common cancer-affecting women with the most common subtype is HER2 positive breast cancer. Patients with HER2 positive breast cancer are treated with Herceptin, a monoclonal anti-HER2 antibody that is proven to improve survival. Unfortunately, the incidence of primary or ac...
Saved in:
Main Author: | Ali, Nursyazana Aqilah |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2021
|
Subjects: | |
Online Access: | http://eprints.usm.my/57782/1/NURSYAZANA%20AQILAH%20BINTI%20ALI-FINAL%20THESIS%20P-UM000817%28R%29-24%20pages.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the expression of HMGCR in HER2 negative and HER2 positive breast cancer
by: Drahman, Rosmaizan
Published: (2022) -
BCL-2, HER1, HER2, HER3 and HER4 expression in primary colorectal adenocarcinoma
by: Ahmad Zubir, Nurul Mahirah
Published: (2017) -
Pathologic parameters in breast cancer does HER2 amplification levels matter /
by: Yong, Swee Guan
Published: (2019) -
Synthesis and characterization of hyperthermia induced spions-peg-her in targeted breast cancer
by: Almaki, Javad Hamzehalipour
Published: (2017) -
The roles of circulating neonatal
nav1.5 (NNAV1.5) and its antibodies in
cancer progression of 4T1 orthotopic
mice model and breast cancer
patients
by: Rajaratinam, Harishini A/P
Published: (2023)